Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1983 1
1985 1
1988 1
1989 1
1990 3
1991 1
1993 1
1995 1
1996 2
1997 3
1998 3
1999 1
2000 7
2002 4
2003 4
2004 2
2005 1
2006 5
2007 4
2008 6
2009 10
2010 9
2011 14
2012 6
2013 15
2014 17
2015 19
2016 12
2017 16
2018 10
2019 14
2020 25
2021 28
2022 25
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Results by year

Filters applied: . Clear all
Page 1
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Assessing floppy infants: a new module.
Cutrona C, Pede E, De Sanctis R, Coratti G, Tiberi E, Luciano R, Pera MC, Velli C, Capasso A, Vento G, Romeo DM, Pane M, Mercuri E. Cutrona C, et al. Among authors: luciano r. Eur J Pediatr. 2022 Jul;181(7):2771-2778. doi: 10.1007/s00431-022-04476-x. Epub 2022 May 4. Eur J Pediatr. 2022. PMID: 35504981 Free PMC article.
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Calcinotto A, Spataro C, Zagato E, Di Mitri D, Gil V, Crespo M, De Bernardis G, Losa M, Mirenda M, Pasquini E, Rinaldi A, Sumanasuriya S, Lambros MB, Neeb A, Lucianò R, Bravi CA, Nava-Rodrigues D, Dolling D, Prayer-Galetti T, Ferreira A, Briganti A, Esposito A, Barry S, Yuan W, Sharp A, de Bono J, Alimonti A. Calcinotto A, et al. Among authors: luciano r. Nature. 2018 Jul;559(7714):363-369. doi: 10.1038/s41586-018-0266-0. Epub 2018 Jun 27. Nature. 2018. PMID: 29950727 Free PMC article.
Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney.
Abedini A, Zhu YO, Chatterjee S, Halasz G, Devalaraja-Narashimha K, Shrestha R, S Balzer M, Park J, Zhou T, Ma Z, Sullivan KM, Hu H, Sheng X, Liu H, Wei Y, Boustany-Kari CM, Patel U, Almaani S, Palmer M, Townsend R, Blady S, Hogan J, Morton L, Susztak K; TRIDENT Study Investigators. Abedini A, et al. J Am Soc Nephrol. 2021 Mar;32(3):614-627. doi: 10.1681/ASN.2020050757. Epub 2021 Feb 2. J Am Soc Nephrol. 2021. PMID: 33531352 Free PMC article.
Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.
Moledina DG, Obeid W, Smith RN, Rosales I, Sise ME, Moeckel G, Kashgarian M, Kuperman M, Campbell KN, Lefferts S, Meliambro K, Bitzer M, Perazella MA, Luciano RL, Pober JS, Cantley LG, Colvin RB, Wilson FP, Parikh CR. Moledina DG, et al. Among authors: luciano rl. J Clin Invest. 2023 Jul 3;133(13):e168950. doi: 10.1172/JCI168950. J Clin Invest. 2023. PMID: 37395276 Free PMC article.
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.
Basile G, Bandini M, Gibb EA, Ross JS, Raggi D, Marandino L, Costa de Padua T, Crupi E, Colombo R, Colecchia M, Lucianò R, Nocera L, Moschini M, Briganti A, Montorsi F, Necchi A. Basile G, et al. Among authors: luciano r. Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158. Clin Cancer Res. 2022. PMID: 36190522 Clinical Trial.
New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
Luciano R, Battafarano G, Saracino R, Rossi M, Perrotta A, Manco M, Muraca M, Del Fattore A. Luciano R, et al. Curr Cancer Drug Targets. 2017;17(3):203-220. doi: 10.2174/1568009616666160813190732. Curr Cancer Drug Targets. 2017. PMID: 27528362 Review.
Nanoparticles-Based Treatment for Bone Metastasis.
Saracino R, Luciano R, Battafarano G, Perrotta A, Muraca M, Del Fattore A. Saracino R, et al. Among authors: luciano r. Curr Drug Targets. 2016;17(3):303-10. doi: 10.2174/1389450116666150427154706. Curr Drug Targets. 2016. PMID: 25915486 Review.
Review of select causes of drug-induced AKI.
Perazella MA, Luciano RL. Perazella MA, et al. Among authors: luciano rl. Expert Rev Clin Pharmacol. 2015;8(4):367-71. doi: 10.1586/17512433.2015.1045489. Expert Rev Clin Pharmacol. 2015. PMID: 26109096 Review. No abstract available.
246 results